{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:42:07Z","timestamp":1794613327105,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Independence Research Fund Denmark","award":["1057-00018b"],"award-info":[{"award-number":["1057-00018b"]}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","award":["R351-A20092"],"award-info":[{"award-number":["R351-A20092"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04149-0","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T14:50:38Z","timestamp":1748875838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High-risk human papillomavirus testing in first-void urine as a novel and non-invasive cervical cancer screening modality\u2014a Danish diagnostic test accuracy study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-6694","authenticated-orcid":false,"given":"Mette","family":"Tranberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severien","family":"Van Keer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Winther","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Bor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Omann","family":"Binderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Blach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"4149_CR1","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, Ronco G, Anttila A, Meijer CJLM, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30:F88\u201399.","journal-title":"Vaccine"},{"issue":"9916","key":"4149_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. The Lancet. 2014;383(9916):524\u201332.","journal-title":"The Lancet"},{"key":"4149_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4823","volume":"363","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363: k4823.","journal-title":"BMJ"},{"key":"4149_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100235","volume":"11","author":"F Inturrisi","year":"2021","unstructured":"Inturrisi F, Aitken CA, Melchers WJG, van den Brule AJC, Molijn A, Hinrichs JWJ, et al. Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study. Lancet Reg Health Eur. 2021;11: 100235.","journal-title":"Lancet Reg Health Eur"},{"key":"4149_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106900","volume":"154","author":"B Serrano","year":"2022","unstructured":"Serrano B, Ib\u00e1\u00f1ez R, Robles C, Peremiquel-Trillas P, de Sanjos\u00e9 S, Bruni L. Worldwide use of HPV self-sampling for cervical cancer screening. Prev Med. 2022;154: 106900.","journal-title":"Prev Med"},{"issue":"1","key":"4149_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12885-018-4165-4","volume":"18","author":"M Tranberg","year":"2018","unstructured":"Tranberg M, Bech BH, Blaak\u00e6r J, Jensen JS, Svanholm H, Andersen B. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures-a randomized controlled trial. BMC Cancer. 2018;18(1):273.","journal-title":"BMC Cancer"},{"key":"4149_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP.S9908","volume":"2","author":"R Erichsen","year":"2010","unstructured":"Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol. 2010;2:51\u20136.","journal-title":"Clin Epidemiol"},{"issue":"10","key":"4149_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/14787210.2019.1668776","volume":"17","author":"J Pattyn","year":"2019","unstructured":"Pattyn J, Van Keer S, T\u00e9blick L, Van Damme P, Vorsters A. HPV DNA detection in urine samples of women: \u201can efficacious and accurate alternative to cervical samples?\u201d Expert Rev Anti Infect Ther. 2019;17(10):755\u20137.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4149_CR9","doi-asserted-by":"publisher","first-page":"g5264","DOI":"10.1136\/bmj.g5264","volume":"349","author":"N Pathak","year":"2014","unstructured":"Pathak N, Dodds J, Zamora J, Khan K. Accuracy of urinary human papillomavirus testing for presence of cervical HPV systematic review and meta analysis. BMJ. 2014;349:g5264.","journal-title":"BMJ"},{"issue":"5","key":"4149_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10096-011-1358-z","volume":"31","author":"A Vorsters","year":"2012","unstructured":"Vorsters A, Micalessi I, Bilcke J, Ieven M, Bogers J, Van Damme P. Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis. 2012;31(5):627\u201340.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"4149_CR11","doi-asserted-by":"crossref","unstructured":"Lefeuvre C, Pivert A, Guillou-Guillemette HL, Lunel-Fabiani F, Veillon P, Le Duc-Banaszuk AS, et al. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France. J Infect. 2020;81(2):248\u201354.","DOI":"10.1016\/j.jinf.2020.05.006"},{"issue":"1","key":"4149_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12879-020-05663-7","volume":"20","author":"M Tranberg","year":"2020","unstructured":"Tranberg M, Jensen JS, Bech BH, Andersen B. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays. BMC Infect Dis. 2020;20(1):926.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4149_CR13","first-page":"513","volume":"163","author":"JW Sellors","year":"2000","unstructured":"Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ\u202f: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne. 2000;163(5):513\u20138.","journal-title":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne"},{"issue":"3","key":"4149_CR14","volume":"11","author":"D \u00d8rnskov","year":"2021","unstructured":"\u00d8rnskov D, Jochumsen K, Steiner PH, Grunnet IM, Lykkebo AW, Waldstr\u00f8m M. Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women referred for colposcopy. A cross-sectional study BMJ Open. 2021;11(3): e041512.","journal-title":"A cross-sectional study BMJ Open"},{"key":"4149_CR15","doi-asserted-by":"crossref","unstructured":"Rohner E, Rahangdale L, Sanusi B, Knittel AK, Vaughan L, Chesko K, et al. Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia. J Clin Microbiol. 2020;58(3):e01443-19","DOI":"10.1128\/JCM.01443-19"},{"issue":"9","key":"4149_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/1471-0528.14682","volume":"124","author":"A Leeman","year":"2017","unstructured":"Leeman A, Del Pino M, Molijn A, Rodriguez A, Torn\u00e9 A, de Koning M, et al. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population. BJOG. 2017;124(9):1356\u201363.","journal-title":"BJOG"},{"key":"4149_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105271","volume":"155","author":"S Van Keer","year":"2022","unstructured":"Van Keer S, Latsuzbaia A, Vanden Broeck D, De Sutter P, Donders G, Doyen J, et al. Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study. J Clin Virol. 2022;155: 105271.","journal-title":"J Clin Virol"},{"issue":"3","key":"4149_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ygyno.2021.06.010","volume":"162","author":"S Van Keer","year":"2021","unstructured":"Van Keer S, Peeters E, Vanden Broeck D, De Sutter P, Donders G, Doyen J, et al. Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol. Gynecol Oncol. 2021;162(3):575\u201383.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"4149_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025388","volume":"9","author":"A Sargent","year":"2019","unstructured":"Sargent A, Fletcher S, Bray K, Kitchener HC, Crosbie EJ. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening. BMJ Open. 2019;9(4): e025388.","journal-title":"BMJ Open"},{"issue":"1","key":"4149_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/LGT.0000000000000352","volume":"22","author":"AT Lorenzi","year":"2018","unstructured":"Lorenzi AT, Fregnani JHT, Dockter J, Fitzgerald K, Strohecker E, Eaton B, et al. High-Risk Human Papillomavirus Detection in Urine Samples From a Referral Population With Cervical Biopsy-Proven High-Grade Lesions. J Low Genit Tract Dis. 2018;22(1):17\u201320.","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"4149_CR21","doi-asserted-by":"publisher","first-page":"e010660","DOI":"10.1136\/bmjopen-2015-010660","volume":"6","author":"G Stanczuk","year":"2016","unstructured":"Stanczuk G, Baxter G, Currie H, Lawrence J, Cuschieri K, Wilson A, et al. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study). BMJ open. 2016;6(4):e010660-2015.","journal-title":"BMJ open."},{"issue":"7","key":"4149_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jclinpath-2014-202851","volume":"68","author":"GA Stanczuk","year":"2015","unstructured":"Stanczuk GA, Currie H, Baxter G, Foster A, Gibson L, Graham C, et al. Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment. J Clin Pathol. 2015;68(7):567\u201370.","journal-title":"J Clin Pathol"},{"issue":"4","key":"4149_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jcv.2014.10.001","volume":"61","author":"S Bernal","year":"2014","unstructured":"Bernal S, Palomares JC, Artura A, Parra M, Cabezas JL, Robles A, et al. Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test. Journal of clinical virology\u202f: the official publication of the Pan American Society for Clinical Virology. 2014;61(4):548\u201352.","journal-title":"Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology"},{"issue":"11","key":"4149_CR24","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s10096-014-2147-2","volume":"33","author":"A Vorsters","year":"2014","unstructured":"Vorsters A, Van den Bergh J, Micalessi I, Biesmans S, Bogers J, Hens A, et al. Optimization of HPV DNA detection in urine by improving collection, storage, and extraction. Eur J Clin Microbiol Infect Dis. 2014;33(11):2005\u201314.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"4149_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","volume":"108","author":"JC Gage","year":"2006","unstructured":"Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol. 2006;108(2):264\u201372.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4149_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12905-021-01537-5","volume":"21","author":"MM Jespersen","year":"2021","unstructured":"Jespersen MM, Booth BB, Petersen LK. Can biopsies be omitted after normal colposcopy in women referred with low-grade cervical cytology? A prospective cohort study. BMC Womens Health. 2021;21(1):394.","journal-title":"BMC Womens Health"},{"issue":"1","key":"4149_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/01.lgt.0000192694.85549.3d","volume":"10","author":"RG Pretorius","year":"2006","unstructured":"Pretorius RG, Kim RJ, Belinson JL, Elson P, Qiao YL. Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy. J Low Genit Tract Dis. 2006;10(1):5\u20139.","journal-title":"J Low Genit Tract Dis"},{"issue":"11","key":"4149_CR28","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/ijc.24774","volume":"125","author":"M Arbyn","year":"2009","unstructured":"Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE. How to evaluate emerging technologies in cervical cancer screening? Int J Cancer. 2009;125(11):2489\u201396.","journal-title":"Int J Cancer"},{"key":"4149_CR29","doi-asserted-by":"crossref","unstructured":"Lynge E, Andersen B, Christensen J, Ejersbo D, Jochumsen K, Johansen T, et al. Cervical screening in Denmark\u2013a success followed by stagnation. Acta Oncologica. 2017;57(3):354\u201361.","DOI":"10.1080\/0284186X.2017.1355110"},{"issue":"5","key":"4149_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","volume":"26","author":"PJ Maver","year":"2020","unstructured":"Maver PJ, Poljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect. 2020;26(5):579\u201383.","journal-title":"Clin Microbiol Infect"},{"key":"4149_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jcv.2018.08.006","volume":"107","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Peeters E, Benoy I, Vanden Broeck D, Bogers J, De Sutter P, et al. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples. J Clin Virol. 2018;107:52\u20136.","journal-title":"J Clin Virol"},{"issue":"11","key":"4149_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11): e012799.","journal-title":"BMJ Open"},{"key":"4149_CR33","unstructured":"Noehr DF KH, Nielsen K, Fuglsang K, Hansen K, Petersen LK et al. Udredning, behandling og kontrol of cervical dysplasi (in Danish only) 2012."},{"issue":"6","key":"4149_CR34","first-page":"485","volume":"12","author":"H Richardson","year":"2003","unstructured":"Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer epidemiology, biomarkers & prevention\u202f: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2003;12(6):485\u201390.","journal-title":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"4149_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105638","volume":"170","author":"A O\u0161trbenk Valen\u010dak","year":"2024","unstructured":"O\u0161trbenk Valen\u010dak A, Cuschieri K, Connor L, Zore A, Smrkolj \u0160, Poljak M. Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening. J Clin Virol. 2024;170: 105638.","journal-title":"J Clin Virol"},{"key":"4149_CR36","unstructured":"Altman DG. Practical statistics for medical research: Chapman and Hall\/CRC; 1991."},{"issue":"4","key":"4149_CR37","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/ijc.32291","volume":"145","author":"J Bonde","year":"2019","unstructured":"Bonde J, Bottari F, Parvu V, Pedersen H, Yanson K, Iacobone AD, et al. Bayesian analysis of baseline risk of CIN2 and \u2265CIN3 by HPV genotype in a European referral cohort. Int J Cancer. 2019;145(4):1033\u201341.","journal-title":"Int J Cancer"},{"issue":"2","key":"4149_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"4149_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jbi.2014.02.013","volume":"48","author":"K Hajian-Tilaki","year":"2014","unstructured":"Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014;48:193\u2013204.","journal-title":"J Biomed Inform"},{"issue":"9","key":"4149_CR40","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/ijc.24528","volume":"125","author":"N Wentzensen","year":"2009","unstructured":"Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009;125(9):2151\u20138.","journal-title":"Int J Cancer"},{"issue":"7","key":"4149_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01443610903061736","volume":"29","author":"A Sehgal","year":"2009","unstructured":"Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V. Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices. Journal of obstetrics and gynaecology\u202f: the journal of the Institute of Obstetrics and Gynaecology. 2009;29(7):583\u20139.","journal-title":"Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology"},{"issue":"8","key":"4149_CR42","first-page":"4183","volume":"37","author":"KC Asciutto","year":"2017","unstructured":"Asciutto KC, Henningsson AJ, Borgfeldt H, Darlin L, Borgfeldt C. Vaginal and Urine Self-sampling Compared to Cervical Sampling for HPV-testing with the Cobas 4800 HPV Test. Anticancer Res. 2017;37(8):4183\u20137.","journal-title":"Anticancer Res"},{"key":"4149_CR43","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2147\/IJWH.S416520","volume":"15","author":"YH Shih","year":"2023","unstructured":"Shih YH, Sun L, Hsu ST, Chen MJ, Lu CH. Can HPV Test on Random Urine Replace Self-HPV Test on Vaginal Self-Samples or Clinician-Collected Cervical Samples? Int J Womens Health. 2023;15:1421\u20139.","journal-title":"Int J Womens Health"},{"key":"4149_CR44","doi-asserted-by":"crossref","unstructured":"Ertik FC, Kampers J, H\u00fclse F, Stolte C, B\u00f6hmer G, Hillemanns P, et al. CoCoss-Trial: Concurrent Comparison of Self-Sampling Devices for HPV-Detection. Int J Environ Res Public Health. 2021;18(19):10388.","DOI":"10.3390\/ijerph181910388"},{"issue":"11","key":"4149_CR45","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jclinpath-2018-205271","volume":"71","author":"M van Zummeren","year":"2018","unstructured":"van Zummeren M, Leeman A, Kremer WW, Bleeker MCG, Jenkins D, van de Sandt M, et al. Three-tiered score for Ki-67 and p16(ink4a) improves accuracy and reproducibility of grading CIN lesions. J Clin Pathol. 2018;71(11):981\u20138.","journal-title":"J Clin Pathol"},{"key":"4149_CR46","volume":"349","author":"HC Kitchener","year":"2014","unstructured":"Kitchener HC, Owens GL. Urine testing for HPV Bmj. 2014;349: g5542.","journal-title":"Urine testing for HPV Bmj"},{"key":"4149_CR47","doi-asserted-by":"crossref","unstructured":"Van Keer SA-O, T\u00e9blick LA-O, Donders G, Weyers S, Doyen J, Cornelis A, et al. Clinical and Analytical Evaluation of the Abbott Alinity m HR HPV Assay in a New Generation First-Void Urine Collector.\u00a02025;97(2):e70254.","DOI":"10.1002\/jmv.70254"},{"key":"4149_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2023.04.022","volume":"174","author":"MH Stoler","year":"2023","unstructured":"Stoler MH, Parvu V, Yanson K, Andrews J, Vaughan L. Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial. Gynecol Oncol. 2023;174:68\u201375.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"4149_CR49","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-21-3710","volume":"28","author":"R van den Helder","year":"2022","unstructured":"van den Helder R, Steenbergen RDM, van Splunter AP, Mom CH, Tjiong MY, Martin I, et al. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection. Clin Cancer Res. 2022;28(10):2061\u20138.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4149_CR50","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1038\/s41598-021-87329-1","volume":"11","author":"S Van Keer","year":"2021","unstructured":"Van Keer S, van Splunter AP, Pattyn J, De Smet A, Herzog SA, Van Ostade X, et al. Triage of human papillomavirus infected women by methylation analysis in first-void urine. Sci Rep. 2021;11(1):7862.","journal-title":"Sci Rep"},{"issue":"6","key":"4149_CR51","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/ijc.26147","volume":"130","author":"P Giorgi-Rossi","year":"2012","unstructured":"Giorgi-Rossi P, Franceschi S, Ronco G. HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. Int J Cancer. 2012;130(6):1387\u201394.","journal-title":"Int J Cancer"},{"key":"4149_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.111227","volume":"166","author":"AR Brentnall","year":"2024","unstructured":"Brentnall AR, Cuschieri K, Sargent A, Berkhof J, Rebolj M. Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening. J Clin Epidemiol. 2024;166: 111227.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04149-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04149-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04149-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T16:03:31Z","timestamp":1748880211000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04149-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4149"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04149-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was listed in the record of processing activities for research projects in the Central Denmark Region (j.no. 1\u201316-02\u2013313-21) and approved by the Ethics Committee in the Central Denmark Region (j. no: 1\u201310-72\u2013246-21). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Seegene sponsors the Allplex HR HPV assays for the study. According to the contract between Seegene and the University Research Clinic for Cancer Screening and Dept. of Pathology, Randers Regional Hospital, Seegene had no influence on the scientific process and no editorial rights pertaining to this manuscript. The authors retained the right to submit the manuscript. MT and JSJ have participated in other studies with HPV test kits sponsored by Roche. MT has received honoraria fee from Roche Diagnostics and AstraZeneca for lectures on HPV self-sampling and HPV triage-methods, respectively. SVK was supported by a junior postdoctoral fellowship of the Research Foundation \u2013 Flanders (grant no: 1240220 N). The University of Antwerp received payment for participation of SVK in an Advisory Board of Novosanis (Subsidiary of OraSure Technologies Inc, Wijnegem, Belgium). All funds are handled and managed by the University of Antwerp. LWG and AH: Have outside this project, received free-of-charge test kits from Roche Diagnostics and AH has received honoraria fee from Exeltis. PN, PB, KOB, and CB: No competing interests. AV: is co-founder of and former board member of Novosanis (Subsidiary of OraSure Technologies Inc, Wijnegem, Belgium), a spin-off company of the University of Antwerp, and was minority shareholder until January 2019.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}